Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Platelet-rich plasma therapy improves oral lichen planus symptoms with few side effects.

PRP and ADSC therapies show promise in improving symptoms of genital lichen sclerosus with minimal side effects.

Vitiligo causes significant emotional stress in Africa, the Middle East, and Latin America, with limited treatment options available.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

Hair-loss trials have increased, but need more diverse participants and standardized measures.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Alopecia areata in Saudi Arabia is costly, mainly due to lost productivity and drug costs.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Alopecia patients in Hebei, China, have poor knowledge and negative attitudes but take proactive steps to manage the condition.

Light-based therapy can help regrow hair in different types of hair loss, but more research is needed.

Improving education, insurance, and support can help scarring alopecia patients access better care.

Iron chelators can effectively reduce hair loss and improve hair growth in autoimmune alopecia.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Alopecia areata causes sudden hair loss, often resolves within a year, but can recur.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

Mesenchymal stem cells can help repair body tissues with low risk of rejection.

Skin stem cells interacting with their environment is crucial for maintaining and regenerating skin and hair, and understanding this can help develop new treatments for skin and hair disorders.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

NK cells play a role in skin diseases like eczema and psoriasis.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.